NNC0519-0130
A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine
Novo Nordisk · Phase 1 · Completed · Enrollment 46
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part 1a: NNC0519-0130 C and NNC0519-0130 B | n/r | n/r | n/r | n/r | n/r |
| Part 1b: NNC0519-0130 B and NNC0519-0130 C | n/r | n/r | n/r | n/r | n/r |
| Part 2a: NNC0519-0130 B and NNC0519-0130 C | n/r | n/r | n/r | n/r | n/r |
| Part 2b: NNC0519-0130 C and NNC0519-0130 B | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.